Biology Reference
In-Depth Information
51. Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM
(2011) High loading efficiency and sustained release of siRNA encapsulated in PLGA nano-
particles: quality by design optimization and characterization. Eur J Pharm Biopharm
77:26-35
52. Zhou J, Patel TR, Fu M, Bertram JP, Saltzman WM (2012) Octa-functional PLGA nanopar-
ticles for targeted and efficient siRNA delivery to tumors. Biomaterials 33:583-591
53. Fischer W, Calderon M, Schulz A, Andreou I, Weber M, Haag R (2010) Dendritic polyglyc-
erols with oligoamine shells show low toxicity and high siRNA transfection efficiency
in vitro. Bioconjug Chem 21:1744-1752
54. Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB,
Schmitz A, Nyengaard JR, Besenbacher F, Kjems J (2006) RNA interference in vitro and
in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 14:476-484
55. Manickam DS, Li J, Putt DA, Zhou QH, Wu C, Lash LH, Oupicky D (2010) Effect of innate
glutathione levels on activity of redox-responsive gene delivery vectors. J Control Release
141:77-84
56. Read ML, Bremner KH, Oupicky D, Green NK, Searle PF, Seymour LW (2003) Vectors
based on reducible polycations facilitate intracellular release of nucleic acids. J Gene Med
5:232-245
57. Read ML, Singh S, Ahmed Z, Stevenson M, Briggs SS, Oupicky D, Barrett LB, Spice R,
Kendall M, Berry M, Preece JA, Logan A, Seymour LW (2005) A versatile reducible polyca-
tion-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res
33:e86
58. Beloor J, Choi CS, Nam HY, Park M, Kim SH, Jackson A, Lee KY, Kim SW, Kumar P, Lee
SK (2012) Arginine-engrafted biodegradable polymer for the systemic delivery of therapeu-
tic siRNA. Biomaterials 33:1640-1650
59. Won YW, Yoon SM, Lee KM, Kim YH (2011) Poly(oligo-D-arginine) with internal disulfide
linkages as a cytoplasm-sensitive carrier for siRNA delivery. Mol Ther 19:372-380
60. Shim MS, Kwon YJ (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J
277:4814-4827
61. Zidovska A, Evans HM, Ahmad A, Ewert KK, Safinya CR (2009) The role of cholesterol and
structurally related molecules in enhancing transfection of cationic liposome-DNA com-
plexes. J Phys Chem B 113:5208-5216
62. Phalon C, Rao DD, Nemunaitis J (2010) Potential use of RNA interference in cancer therapy.
Expert Rev Mol Med 12:e26
63. McNamara JO II, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA,
Giangrande PH (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
Nat Biotechnol 24:1005-1015
64. Morris MC, Deshayes S, Heitz F, Divita G (2008) Cell-penetrating peptides: from molecular
mechanisms to therapeutics. Biol Cell 100:201-217
65. Terrone D, Sang SL, Roudaia L, Silvius JR (2003) Penetratin and related cell-penetrating
cationic peptides can translocate across lipid bilayers in the presence of a transbilayer poten-
tial. Biochemistry 42:13787-13799
66. Thoren PE, Persson D, Isakson P, Goksor M, Onfelt A, Norden B (2003) Uptake of analogs
of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem Biophys Res Commun
307:100-107
67. Katayama S, Hirose H, Takayama K, Nakase I, Futaki S (2011) Acylation of octaarginine:
implication to the use of intracellular delivery vectors. J Control Release 149:29-35
68. Dominska M, Dykxhoorn DM (2010) Breaking down the barriers: siRNA delivery and endo-
some escape. J Cell Sci 123:1183-1189
69. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL (2003) Distinct endocytic pathways
regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5:410-421
70. Sioud M (2006) Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol
Med 12:167-176
71. Sioud M (2006) RNA interference below the immune radar. Nat Biotechnol 24:521-522
Search WWH ::
Custom Search